Fundraising FoxGlobal Health Investment Fund — Full Portfolio
7 tracked investments · listed companies and verified rows first
Alydia Health manufactures the JADA System, an intrauterine device that uses low-level vacuum to control postpartum hemorrhage in hospital settings.
HealthtechMedical Devices
Co-investorsAstiaAvestria VenturesGlobal Health Investment Corporation
HealthtechReno, US
Tsontcho Ianchulev(Executive Officer, Director)Charles Warden(Director)Brian Walsh(Executive Officer, Director)Bruce J. Brumfield, Jr.(Director)Glenn Rockman(Director)inJim Mazzo(Director)
Co-investorsGlobal Health Investment CorporationVisionary VenturesVisionary Venture
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)inAmelia Degenkolb(Executive Officer, Director)in
BoardLilly DeSouza Burr(Director)Curt LaBelle(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)in
Co-investorsAvestria VenturesForeground CapitalLaerdal Million Lives FundTullis Health Investors
Ophirex is a biotech company developing varespladib, an investigational oral capsule intended to treat snakebite envenomation by inactivating a key venom toxin found in most snake species.
BiotechDeep TechHealthtechCorte Madera, US
Jerry Harrison(Co-founder; Director)Matthew R. Lewin(Founder and Board Member)inJeremy Gowler(Chief Executive Officer & Board Director)inSara Carter(Executive)Timothy Platts-Mills(Executive)Dotson(Finance leader (Controller/Finance))
.jpg)
Co-investorsTullis Health Investors
Themis offers lending backed by non-fungible tokens, allowing holders to deposit an NFT as collateral and borrow against it.
Neepa Patel(Founder)in
Co-investorsGhaf Capital PartnersLD CapitalNFXAdjuvant CapitalFelicis VenturesHadean Ventures+2 more
Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)inDaniel Couto(Executive Officer)inMark Mullikin(Executive Officer)inJeffrey Silber(Executive Officer)inChristopher Viehbacher(Director)
BoardJohn LaMattina(Director)in
Co-investorsAMR Action FundColorcon VenturesK2 HealthVenturesSalica InvestmentsSeventure PartnersBNP Paribas+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Epion Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.